Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5581736 | Clinical Lymphoma Myeloma and Leukemia | 2017 | 20 Pages |
Abstract
General clinical features were comparable with those of Western patients, whereas therapeutic outcomes were slightly inferior. The novel risk assessment model showed potential as a more powerful prognostic tool by identifying 3 subsets of patients with significantly distinct outcomes, which warrants further validations.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Wen-Yan Yu, Mei Geng, Jie Hao, Mei Chen, Su-Jiang Zhang, Jin Wang, Jian-Qing Mi,